Publications en collaboration avec des chercheurs de Vall d'Hebron Institut de Recerca (15)

2024

  1. Characteristics and outcomes of COVID-19 patients admitted to hospital with and without respiratory symptoms

    Heliyon, Vol. 10, Núm. 10

  2. Impact of antimicrobial stewardship in organisms causing nosocomial infection among COVID-19 critically ill adults

    European Journal of Internal Medicine, Vol. 119, pp. 93-98

2023

  1. Key Factors Associated With Pulmonary Sequelae in the Follow-Up of Critically Ill COVID-19 Patients

    Archivos de Bronconeumologia, Vol. 59, Núm. 4, pp. 205-215

2022

  1. Prognostic implications of comorbidity patterns in critically ill COVID-19 patients: A multicenter, observational study

    The Lancet Regional Health - Europe, Vol. 18

  2. The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 119, Núm. 21

2021

  1. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

    Science immunology, Vol. 6, Núm. 62

  2. High rate of infections during ICU admission of patients with severe SARS-CoV-2 pneumonia: A matter of time?

    Journal of Infection

  3. Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial

    The Lancet, Vol. 398, Núm. 10295, pp. 121-130

2020

  1. SARS-CoV-2 in Spanish Intensive Care Units: Early experience with 15-day survival in Vitoria

    Anaesthesia Critical Care and Pain Medicine, Vol. 39, Núm. 5, pp. 553-561

2019

  1. Factors associated with ventilator-associated events: an international multicenter prospective cohort study

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 38, Núm. 9, pp. 1693-1699

2018

  1. Assessing predictive accuracy for outcomes of ventilator-associated events in an international cohort: the EUVAE study

    Intensive Care Medicine, Vol. 44, Núm. 8, pp. 1212-1220

2016

  1. Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic and patient outcomes? An observation from the Defining Antibiotic Levels in Intensive care unit patients (DALI) cohort

    Journal of Antimicrobial Chemotherapy, Vol. 71, Núm. 1, pp. 196-207

2013

  1. Early non-invasive ventilation treatment for severe influenza pneumonia

    Clinical Microbiology and Infection, Vol. 19, Núm. 3, pp. 249-256

2012

  1. Elevation of creatine kinase is associated with worse outcomes in 2009 pH1N1 influenza A infection

    Intensive Care Medicine, Vol. 38, Núm. 7, pp. 1152-1161

2011

  1. Use of early corticosteroid therapy on ICU admission in patients affected by severe pandemic (H1N1)v influenza A infection

    Intensive Care Medicine, Vol. 37, Núm. 2, pp. 272-283